Zymeworks (ZYME) Other Working Capital Changes (2021 - 2026)
Zymeworks' (ZYME) quarterly Other Working Capital Changes came in at -$1.0 million in Q1 2026, up 65.01% year-on-year from -$609065.2 in Q1 2025, and up 95.14% quarter-over-quarter from -$20.7 million in Q4 2025.
Zymeworks (ZYME) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Zymeworks has disclosed Other Working Capital Changes across 6 years of filings, most recently posting -$1.0 million for Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$1.0 million, up 65.01% year-over-year; the trailing twelve-month figure through Mar 2026 was -$21.3 million (down 94.98% YoY), and the FY2025 annual result was -$23.2 million, down 178.72% from the prior year.
- Other Working Capital Changes came in at -$1.0 million for Q1 2026 at Zymeworks, up from -$20.7 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $19.3 million in Q3 2025 to a low of -$20.7 million in Q4 2025.
- The 5-year median for Other Working Capital Changes is -$732000.0 (2024), against an average of -$1.6 million.
- Peak annual rise in Other Working Capital Changes reached 2732.92% in 2025, while the deepest fall reached 2542.71% in 2025.
- Zymeworks' Other Working Capital Changes stood at $642000.0 in 2022, then surged by 2341.59% to $15.7 million in 2023, then sank by 104.99% to -$782000.0 in 2024, then tumbled by 2542.71% to -$20.7 million in 2025, then jumped by 95.14% to -$1.0 million in 2026.
- The last three Other Working Capital Changes figures came in at -$1.0 million (Q1 2026), -$20.7 million (Q4 2025), and $19.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.01 Mn |
| Mar 31, 2026 | -1.01 Mn |
| Dec 31, 2025 | -20.67 Mn |
| Dec 31, 2025 | -20.67 Mn |
| Sep 30, 2025 | 19.27 Mn |
| Sep 30, 2025 | 19.27 Mn |
| Jun 30, 2025 | -18.91 Mn |
| Jun 30, 2025 | -18.91 Mn |
| Mar 31, 2025 | -2.87 Mn |
| Mar 31, 2025 | -2.87 Mn |
| Dec 31, 2024 | -782,000.00 |
| Dec 31, 2024 | -782,000.00 |
| Sep 30, 2024 | -732,000.00 |
| Sep 30, 2024 | -732,000.00 |
| Jun 30, 2024 | -6.54 Mn |
| Jun 30, 2024 | -6.54 Mn |
| Mar 31, 2024 | -259,000.00 |
| Mar 31, 2024 | -259,000.00 |
| Dec 31, 2023 | 15.68 Mn |
| Dec 31, 2023 | 15.68 Mn |